Interview with the Innovators

Interview with the Innovators

New Developments on Prognostic Markers for Patients With Early Breast Cancer
This second installment discusses data presented at ESMO 2023 on prognostic markers for patients with early breast cancer, highlighting data from the monarchE study, the NATALEE study, and the BCIRG 001 and 005 trials.

Recent Clinical Trials of Neoadjuvant Immunotherapy in Breast Cancer
This third installment observes data presented at ESMO 2023 on neoadjuvant immunotherapy in breast cancer, with a discussion of the KEYNOTE-522 study, NeoTRIP study, KEYNOTE-756 study, and the EMBER-2 study.

Educating on HER2-Low mBC

Fostering Shared Treatment Decision-Making

Setting Appropriate Patient Goals of Therapy
In the third video of this series, knowledgeable advance practice providers contribute their viewpoints on the attributes of targeted antibody drug conjugate therapy for mBC that may help some patients fulfill their treatment goals.

Managing Patient Expectations and ADC-Related Side Effects
This video is the fourth in the series where skilled discussants share their approaches to managing patient expectations of treatment and side effects associated with antibody drug conjugate therapy for mBC.

Care Team and Patient Resources and Tools for mBC

Assurance in ADC Therapy for HER2+ or HER2-Low mBC
To conclude this series, our seasoned panel describes how clinical trial and practical experiences with antibody drug conjugate therapy for mBC instill their confidence in this therapy.

Ovarian Function Suppression in Premenopausal Breast Cancer: Are We Making Progress in Educating Patients on When to Start Therapy and the Length of Therapy?
Hear from two breast cancer nurse navigators, Emily Beard, RN, BSN, OCN, CBCN, and Melissa Simon, BSN, RN, OCN, CBCN, ONN-CG, on the progress made in educating patients on when to start ovarian function suppression and the recommended duration of therapy.

How Well Do Patients Tolerate Ovarian Function Suppression? Oncology Nurse Navigators Discuss Their Experience
This Interview with the Innovator video features breast cancer nurse navigators Emily Beard, RN, BSN, OCN, CBCN, and Melissa Simon, BSN, RN, OCN, CBCN, ONN-CG, as they discuss ovarian function suppression, how patients tolerate side effects, and educating patients on expectations of treatment.

Page 2 of 12

Journal of Oncology Navigation & Survivorship
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country